Neurology® Podcast

The August 2026 recall showcases five incredible interviews highlighting recent advances in headache medicine. The episode begins with Dr. Patricia Pozo-Rosich discussing the latest advancements in headache medicine, focusing on key research findings from 2025. The episode continues with Dr. Jennifer Robblee discussing the latest consensus on refractory migraine. In the third episode of this series, Dr. Michael Eller discusses the implications of CGRP therapies in migraine treatment.  The recall concludes with a two-part discussion featuring Drs. Tesha Monteith and Peter Goadsby, who highlight major developments in headache medicine presented at the 2026 AAN Annual Meeting.

 
Podcast links: 
 
The Best of Headache Medicine from 2025: A Year in Review
 
Refractory Headache Disorders, New Consensus, and Emergency Department Migraine Guidelines
 
CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke
 
Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 1 
Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 2 
Article links: 
Reaching International Consensus on the Definition of Refractory Migraine Using the Delphi Method
2025 Guideline Update to Acute Treatment of Migraine for Adults in the Emergency Department
CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke  
Disclosures can be found at Neurology.org.

In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions. 
For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. 
Read more about the Fenebrutinib Trial. 
Disclosures can be found at Neurology.org.

In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data. 
For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. 
Read more about the Fenebrutinib Trial. 
Disclosures can be found at Neurology.org.

Dr. Dara Albert talks with Dr. Jon Stone about the latest advancements in FND from the recent International Conference on Functional Neurological Disorder. Dr. Jon Stone shares insights on the field's growth, multidisciplinary care, cultural perspectives, and future directions.
Check out the FNDS website for more information about FND. 
Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. John Ney about the link between military sexual trauma and migraine among US veterans. 
Read the related article in Neurology® Clinical Practice. 
Disclosures can be found at Neurology.org.